| Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy G Luo, A Ambati, L Lin, M Bonvalet, M Partinen, X Ji, HT Maecker, ... Proceedings of the National Academy of Sciences 115 (52), E12323-E12332, 2018 | 189 | 2018 |
| Targeted degradation of the cyclin-dependent kinase inhibitor ICK4/KRP6 by RING-type E3 ligases is essential for mitotic cell cycle progression during Arabidopsis gametogenesis J Liu, Y Zhang, G Qin, T Tsuge, N Sakaguchi, G Luo, K Sun, D Shi, S Aki, ... The Plant Cell 20 (6), 1538-1554, 2008 | 177 | 2008 |
| Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases G Luo, L Lin, L Jacob, M Bonvalet, A Ambati, G Plazzi, F Pizza, R Leib, ... PloS one 12 (12), e0187305, 2017 | 38 | 2017 |
| Four Closely‐related RING‐type E3 Ligases, APD1–4, are Involved in Pollen Mitosis II Regulation in Arabidopsis G Luo, H Gu, J Liu, LJ Qu Journal of integrative plant biology 54 (10), 814-827, 2012 | 31 | 2012 |
| Narcolepsy risk loci outline role of T cell autoimmunity and infectious triggers in narcolepsy HM Ollila, E Sharon, L Lin, N Sinnott-Armstrong, A Ambati, SM Yogeshwar, ... Nature communications 14 (1), 2709, 2023 | 21 | 2023 |
| Narcolepsy risk loci are enriched in immune cells and suggest autoimmune modulation of the T cell receptor repertoire HM Ollila, E Sharon, L Lin, N Sinnott-Armstrong, A Ambati, RP Hillary, ... Biorxiv, 373555, 2018 | 17 | 2018 |
| T cell reactivity to regulatory factor X4 in type 1 narcolepsy G Luo, S Yogeshwar, L Lin, EJM Mignot Scientific Reports 11 (1), 7841, 2021 | 12 | 2021 |
| Characterization of T cell receptors reactive to HCRTNH2, pHA273-287, and NP17-31 in control and narcolepsy patients G Luo, J Zhang, L Lin, EJM Mignot Proceedings of the National Academy of Sciences 119 (32), e2205797119, 2022 | 11 | 2022 |
| Multiancestry analysis of the HLA locus in Alzheimer’s and Parkinson’s diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes Y Le Guen, G Luo, A Ambati, V Damotte, I Jansen, E Yu, A Nicolas, ... Proceedings of the National Academy of Sciences 120 (36), e2302720120, 2023 | 10 | 2023 |
| Mass spectrometric characterization of narcolepsy-associated pandemic 2009 influenza vaccines A Ambati, G Luo, E Pradhan, J Louis, L Lin, RD Leib, HM Ollila, T Poiret, ... Vaccines 8 (4), 630, 2020 | 8 | 2020 |
| Treatment of narcolepsy with natalizumab TE Scammell, G Luo, P Borker, L Sullivan, K Biddle, E Mignot Sleep 43 (7), zsaa050, 2020 | 6 | 2020 |
| Response to “H1N1 hemagglutinin-specific HLA-DQ6-restricted CD4+ T cells can be readily detected in narcolepsy type 1 patients and healthy controls” E Mignot, A Ambati, G Luo Journal of Neuroimmunology 333, 2019 | 6 | 2019 |
| Protective association of HLA‐DRB1*04 subtypes in neurodegenerative diseases implicates acetylated tau PHF6 sequences YL Guen, G Luo, A Ambati, V Damotte, IE Jansen, E Yu, A Nicolas, ... Alzheimer's & Dementia 18, e060159, 2022 | 5 | 2022 |
| Autoimmunity to hypocretin and molecular mimicry to flu antigens in Type 1 narcolepsy G Luo, A Ambati, L Lin, M Bonvalet, M Partinen, X Ji, HT Maecker, ... bioRxiv, 378109, 2018 | 5 | 2018 |
| HLA-DQB1* 05 subtypes and not DRB1* 10: 01 mediates risk in anti-IgLON5 disease SM Yogeshwar, S Muñiz-Castrillo, L Sabater, V Peris-Sempere, ... Brain, awae048, 2024 | 3 | 2024 |
| Protective association of HLA-DRB1* 04 subtypes in neurodegenerative diseases implicates acetylated tau PHF6 sequences E Mignot, Y Le Guen, G Luo, A Ambati, V Damotte, I Jansen, E Yu, ... | 1 | 2022 |
| Correction: Absence of anti-hypocretin receptor 2 autoantibodies in post pandemrix narcolepsy cases G Luo, L Lin, L Jacob, M Bonvalet, A Ambati, G Plazzi, F Pizza, R Leib, ... Plos one 14 (3), e0214340, 2019 | 1 | 2019 |
| HLA and KIR genetic association and NK cells in anti-NMDAR encephalitis V Peris Sempere, G Luo, S Muñiz-Castrillo, AL Pinto, G Picard, ... Frontiers in Immunology 15, 1423149, 2024 | | 2024 |
| Hypocretin loss in Pandemrix-vaccinated mice G Luo Sleep 47 (4), zsae029, 2024 | | 2024 |
| Rank Wise Effect of HLA-DQ5 Explains Risk for the Development of Anti-IgLON5 Disease S Yogeshwar, V Peris-Sempere, S Muñiz-Castrillo, G Luo, C Finke, ... Neurology 99 (23_Supplement_2), S49-S49, 2022 | | 2022 |
